Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.4.2.1. Nucleoside/Nucleotide reverse transcriptase inhibitors |
Others observations: (tenofovir disoproxil fumarate – equivalent to 245 mg tenofovir disoproxil). Also indicated for pre-exposure prophylaxis. |
| WHO Model List of Essential Medicines (2021) | 6.4.4.1.1 Nucleoside/Nucleotide reverse transcriptase inhibitors |
Others observations: (tenofovir disoproxil fumarate – equivalent to 245 mg tenofovir disoproxil). |
| PAHO Strategic Fund Medicine List | 2.6.4.1. Medicines for Hepatitis B | No observations |
| Chile | Essential and Prioritized Medications | No observations |